Which has the lower trailing P/E, ASND or SOLV?

SOLV has the lower trailing P/E: ASND trades at 17.33 and SOLV at 10.75. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, ASND or SOLV?

Over the past five years, ASND grew revenue faster — ASND at a 189.92% CAGR versus SOLV at 2.72%.

Is ASND or SOLV more profitable?

ASND runs the higher net margin — ASND at 71.08% versus SOLV at 17.26%.

Ascendis Pharma A/S (ASND) vs Solventum Corporation (SOLV)

A side-by-side comparison of Ascendis Pharma A/S and Solventum Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ASND

Ascendis Pharma A/S

$14.16B

$228.03HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

SOLV

Solventum Corporation

$15.24B

$88.03HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

Total return — ASND vs SOLV

growth of $100 · dividends reinvested · last 3y

ASND +57.8% (+16.4%/yr)SOLV +10.0% (+3.2%/yr)ASND compounded faster over this window

ASND SOLV

ASND vs SOLV: by the numbers

•SOLV is the larger company ($15.24B vs $14.16B market cap).
•SOLV trades at the lower trailing earnings multiple (10.75 vs 17.33 P/E), one valuation lens rather than an overall verdict.
•ASND converts more revenue to profit (71.08% vs 17.26% net margin).
•ASND grew revenue faster over the past five years (189.92% vs 2.72% CAGR).

Metrics side by side

Valuation

Metric	ASND	SOLV
P/E ratio	17.33	10.75
Forward P/E	N/A	12.29
PEG ratio	N/A	1.76
P/S ratio	11.59	1.83
P/B ratio	8.64	3.18
EV / EBITDA	93.79	7.07
FCF yield	2.73%	N/A

Profitability

Metric	ASND	SOLV
Gross margin	90.18%	54.69%
Operating margin	-18.92%	24.99%
Net margin	71.08%	17.26%
ROE	52.97%	29.88%
ROIC	5.85%	15.85%

Growth (annualized)

Metric	ASND	SOLV
Revenue CAGR (5Y)	189.92%	2.72%
EPS CAGR (5Y)	N/A	6.26%
Total return CAGR (5Y)	7.40%	N/A

Frequently asked

Which has the lower trailing P/E, ASND or SOLV?: SOLV has the lower trailing P/E: ASND trades at 17.33 and SOLV at 10.75. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, ASND or SOLV?: Over the past five years, ASND grew revenue faster — ASND at a 189.92% CAGR versus SOLV at 2.72%.
Is ASND or SOLV more profitable?: ASND runs the higher net margin — ASND at 71.08% versus SOLV at 17.26%.

Go deeper

Full ASND analysis Full SOLV analysis Interactive comparison tool

Dig into the metrics

Ascendis Pharma A/S P/E ratio Solventum P/E ratio Ascendis Pharma A/S ROE Solventum ROE Ascendis Pharma A/S operating margin Solventum operating margin Ascendis Pharma A/S revenue growth Solventum revenue growth Ascendis Pharma A/S free cash flow Solventum free cash flow

Ascendis Pharma A/S & Solventum appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest 10-Year Total Return Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.